- Assessment and Diagnosis
- Circadian Rhythm Disorders
- Comorbid Conditions
- Dreaming and Parasomnias
- Insomnia
- Neurologic and Psychiatric Disorders
- Nonpharmacologic Treatment
- Pharmacotherapy
- Public Policy and Health
- Restless Legs Syndrome
- Scientific Perspectives
- Sleep Deprivation
- Sleep Physiology
- Sleep-Related Breathing Disorders
- Sleepiness
- Special Patient Populations
Editor-in-Chief
Director of the Sleep Disorders and Research Center at Henry Ford Health System in Detroit, Mich.
Dr. Roth’s research primarily focuses on sleep processes. His work includes research on sleep loss, sleep fragmentation, and deviation from sleep processes, including pharmacologic effects and sleep pathologies.
Dr. Roth has held numerous leadership positions within his field. He is past chairman of the National Center on Sleep Disorders Research Advisory Board at the National Institutes of Health and past president of the United States Sleep Research Society, the American Sleep Disorders Association, and the National Sleep Foundation. He also served as editor-in-chief of the journal Sleep.
In addition to his position at Henry Ford, he is a clinical professor of psychiatry at the University of Michigan School of Medicine in Ann Arbor.
He has published more than 310 manuscripts, 12 edited volumes, 150 chapters, and 450 abstracts.
Dr. Roth received his doctorate degree from the University of Cincinnati in 1970.
Continuing Education Activities
Editor-in-Chief, SLEEPClinician™
Clinical Professor of Psychiatry
University of Michigan School of Medicine
Ann Arbor, Michigan
Director
Sleep Disorders and Research Center
Henry Ford Hospital
Detroit, Michigan
Professor of Nursing
Chair, Behavioral and Health Sciences Division
School of Nursing
Center for Sleep and Respiratory Neurobiology
Division of Sleep Medicine
School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania
Neurology Service, Multidisciplinary Sleep Unit, Hospital Clínic...
Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a
Positional therapy for obstructive sleep apnea: An objective measurement of patients' usage and efficacy at home
Impact of sleep apnea on economics
Université Paris Descartes, Sorbonne Paris...
Opioids, sleep, and sleep-disordered breathing.
Cardiovascular Research Institute, University of California, San...
During the past several years, the relationship between cardiovascular disease (CVD) and obstructive sleep apnea (OSA) has been the subject of intense investigation.
The relationship between obstructive sleep apnea (OSA) and systemic hypertension is thought to be causal, but conclusive proof remains elusive because of the number of confounding elements, most notably obesity.
The purpose of this review is to improve our understanding of the causes and consequences of nonadherence to PAP therapy and highlight interventions that promote adherence.
Positive airway pressure (PAP) is the most common form of treatment for obstructive sleep apnea (OSA). Treatment adherence is notoriously low, and holidays from treatment are common.
Findings from population studies evaluating the progression and incidence of sleep disordered breathing have shown evidence of a longitudinal increase in the severity of sleep disordered breathing.